Phase I treatment of women with metastatic breast cancer with baboon anti-gross cystic disease fluid protein.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D001053:Apolipoproteins; D053399:Apolipoproteins D; D001943:Breast Neoplasms / Q000276:immunology / Q000628:therapy*; D002352:Carrier Proteins; D004341:Drug Evaluation; D005260:Female; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D008297:Male; D026901:Membrane Transport Proteins; D010215:Papio / Q000276:immunology
C024328:APOD protein, human; D000912:Antibodies, Neoplasm; D001053:Apolipoproteins; D053399:Apolipoproteins D; D002352:Carrier Proteins; D006023:Glycoproteins; D026901:Membrane Transport Proteins